ABOUT US

Andrew began with Lloyds Private Banking in 1994 as a portfolio manager and client advisor in its UHNW team. In 2002, he moved to the private client division of Williams de Broe, where he oversaw funds grow from £250m to £8b. He was appointed Head of the Investec Private Office in 2014. Andrew joined Brown Shipley Private Bank in 2019, where he created and oversaw the Private Banking Team. Most recently, Andrew worked as Director at The Hottinger Group, where he advised clients and families.

Nikos Anastasiades has almost 20 years of experience in regulatory compliance function units within the financial markets. He has held previous roles at Lamda Development SA, Société Générale Bank & Trust as well as Argus Stockbrokers Ltd. Nikos holds a BSc in
Economics, a BSc in Business Economics and an MA in International Business, as well as AML Certificate, an Advanced Certificate and a Certificate A1 of the Central Bank of Greece and HCMC, and an Equities Trader Certificate (ATHEX).

Anatoly Fedorov is a Portfolio Manager and the Head of Equities of Signet Group. Anatoly manages Signet’s global leaders portfolio and has experience working with Long-short Equity and Merger Arbitrage strategies. Prior to joining the Investment Manager in February 2018, he worked as a Vice President at J.P. Morgan in EMEA Diversified Industrials Practice. Here he conducted financial and valuation analysis, execution, project management and due diligence on large scale M&A transactions (for example from 2016: Philips Lighting IPO and SGD Pharma sell-side). Prior to his employment at J.P. Morgan, Anatoly was an equity research analyst at Genesis Investment Management. During his time there, he executed financial analysis, valuation and communication with corporate management for emerging markets.

Natalia joined Signet in 2020 as Investment Director taking part in managing and developing growing portfolio of healthcare investments in both private and public companies. She has extensive experience in deal sourcing, due diligence, valuation, and execution of life sciences investment opportunities as well as in managing and developing portfolios of biotechnology companies at various stages of development.

Prior to Signet, from 2017 Natalia focused on early-stage private life sciences companies in Europe working within entrepreneurial biotech ecosystem in Europe with academic start-ups and technology transfer offices and contributing to early-stage investment rounds. She also founded and actively fund raised for a seed fund dedicated to building early-stage life sciences ventures.

Prior to healthcare investing, Natalia was a Director at UBS Investment Bank from 2015 where she led structured financing transactions for institutional investors. Her expertise spans various financial products and asset classes with focus on global emerging markets. Her clients include extensive network of European institutional investors such as pension funds, hedge funds and real money asset managers. Natalia started her career in investment banking at Citi in London in 2009 on analyst graduate program and worked in Capital Markets Origination and Global Markets divisions moving on to VTB Capital in 2012.

Natalia holds a BSc in Biochemistry from Imperial College London, MSc Management with a focus on pharmaceutical industry from London School of Economics, and an MEng in Food Technology Engineering from Moscow State University of Applied Biotechnology.

Natalia is fluent in English, Russian, Italian, French and speaks conversational German.

Tushar Jian has 11 years of experience as an equity research analyst with a strong knowledge of analysing financial statements, corporate strategy and industry trends to identify medium- to long-term investment opportunities. He has a strong analytical and quantitative background (MBA from INSEAD, Computer Science from NUS, CFA) which is complemented with around 10 years of equity research experience at Goldman Sachs and the Bank of America Merrill Lynch.

Yiyi Jiang is an Equity Analyst covering the healthcare sector at Signet Capital Management. Prior to joining Signet in 2021, Yiyi was a Senior Equity Analyst at HSBC Asset Management for more than six years covering Healthcare and Tech sectors in developed markets. Before that, she worked as Equity Analyst at Lombard Odier Asset Management and Strategic Investment Advisors. Following her BA in Finance from Renmin University, Yiyi completed her Masters in Economics from Yale University and PhD in Finance from IE Business School.

Prior to joining Signet Management, Dr. Robert Shore was lead biotechnology analyst at Redburn, Europe’s largest
independent equity research shop. This followed several years as a postdoctoral research fellow in molecular biology at
Harvard Medical School, where he developed a model for the ZIKA virus through CRISPR gene editing. Robert holds an
MSc in Bioscience Technology, a PhD in Neurogenetics from the University of St Andrews’ School of Medicine and is
currently an MBA candidate at the University of Cambridge’s Judge Business School.

Robert Marquardt was the Founder of the Signet Group of Companies in the early 1990s and is today Chairman of Signet Wealth Management. Robert, as hedge fund CIO, has managed and advised on investment strategy and hedge fund / alternative investment selection globally since 1994. Through Signet’s offices in Switzerland, London and Hong Kong the group managed and advised on hedge fund selection with an asset level in excess of $3.5 billion at the peak. Prior to founding Signet, Robert was the Managing Director of Chase Private Banking in Luxembourg and a Credit Officer of Chase Manhattan Bank in the Middle East during a 12-year career at the Chase. Robert has deep knowledge of the opportunities and risks in different global economic and market environments across fixed income, equity, commodity and currency strategies through different economic cycles and holding structures.

Daria holds Honours Degrees in Economics and Sociology as well as an M.A. Degree in the Psychology of Personnel Management from the State Education Institution of Higher Professional Education. Today, she heads up Signet’s investor relations and client services, supporting our customers across our full product range.